A Multidisciplinary Discussion on Implementing Integrated Continuous Glucose Monitoring Into Practice (Pharmacist Credit)
1.5 Credit / Endocrinology
View More
A Multidisciplinary Discussion on Implementing Integrated Continuous Glucose Monitoring Into Practice (Pharmacy Technician)
1.5 Credit / Endocrinology
View More
Caring for Patients With EGFR-Positive Non−Small Cell Lung Cancer: An Interactive Review of New Drug Therapies Targeting Exon 20 Insertion Mutations
1.5 Credits / Oncology, Respiratory
View More
Advances in the Management of Prurigo Nodularis: Updates for the Specialty Pharmacist
1.5 Credits / Dermatology, Immunology
View More
Monitoring Use of Current and Emerging Therapies for Beta Thalassemia: Treatment and Management Pearls for Pharmacists
1.0 Credit / Hematology
View More
Directions in Pharmacy: Where We’ve Come From and Where We’re Headed
1.0 Credit / COVID-19, General Pharmacy
View More
Exploring the Novel and Innovative Glucagon Formulations for the Treatment of Severe Hypoglycemia
0.75 Credit / Endocrinology
View More
Exploring DORAs for the Treatment of Insomnia
0.75 Credit / Neurology
View More
Patient Case Study: A Rare Neurological Disease Diagnostic Journey
June 8th 2023Neuromyelitis optica spectrum disorder is an autoimmune disease characterized by severe attacks of optic neuritis and/or myelitis, leading to possible visual loss, paralysis, cognitive impairment, sensory deficits, bladder dysfunction, and even mortality.
Efficacy of Upadacitinib Maintained for 3 Years for Those With Psoriatic Arthritis
June 7th 2023Previously, upadacitinib improved symptoms through 2 years in the SELECT-PsA 1 trial for those with psoriatic arthritis with prior inadequate response or intolerance to ≥1 non-biologic disease-modifying antirheumatic drug.
FDA Grants Fast Track Designation to Milvexian for Multiple Prospective Cardiovascular Indications
June 6th 2023The proposed indications for milvexian include stroke prevention after an acute ischemic stroke or high-risk transient ischemic attack; recent acute coronary syndrome; and atrial fibrillation.
Obstructive Sleep Apnea May Have Significant Impact on Cognitive Decline in Middle-Aged Individuals
Recent debates have surrounded whether cognitive deficits, specifically in middle-aged patients, may be driven by cardiovascular and metabolic comorbidities instead of distinct obstructive sleep apnea processes.